MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

14 Feb 2024 Evaluate
The sales is pegged at Rs. 616.74 millions for the December 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 838.46 millions during the year-ago period.A radical decline of -83.59% was reported in the net profit of the company for the quarter ended December 2023 to Rs. 3.44  millions from Rs. 20.96 millions.A decline of 5.34 millions was observed in the OP in the quarter ended December 2023 from 35.59 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 616.74 838.46 -26.44 1989.19 2414.64 -17.62 3106.46 2217.51 40.09
Other Income 4.21 2.80 50.36 10.65 4.50 136.67 4.78 6.33 -24.49
PBIDT 5.34 35.59 -85.00 22.00 248.65 -91.15 244.06 248.70 -1.87
Interest 2.31 6.24 -62.98 5.82 10.65 -45.35 12.32 6.74 82.79
PBDT 3.03 29.35 -89.68 16.18 238.00 -93.20 231.74 241.96 -4.22
Depreciation 1.62 1.61 0.62 4.87 4.79 1.67 6.43 5.95 8.07
PBT 1.41 27.74 -94.92 11.31 233.21 -95.15 225.31 236.01 -4.53
TAX -2.03 6.78 -129.94 3.64 59.46 -93.88 59.00 64.16 -8.04
Deferred Tax -3.11 2.79 -211.47 0.03 2.01 -98.51 -2.07 0.28 -839.29
PAT 3.44 20.96 -83.59 7.67 173.75 -95.59 166.31 171.85 -3.22
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 0.87 4.24 -79.60 1.11 10.30 -89.26 7.86 11.22 -29.95
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..